Rigel Pharmaceuticals reported $138.94M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acura Pharmaceuticals ACUR:US 1.31M 70K
Agenus AGEN:US $ 290.48M 41.49M
Amgen AMGN:US $ 18520M 865M
Anika Therapeutics ANIK:US $ 165.32M 3.21M
Applied Genetic Technologies AGTC:US $ 70.53M 4.84M
Arrowhead Research ARWR:US $ 417.63M 79.35M
Astrazeneca AZN:US 22.65B 3.6B
AstraZeneca AZN:LN 22.65B 3.6B
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Celldex Therapeutics CLDX:US $ 390.7M 20.14M
Chemocentryx CCXI:US $ 351.63M 82.46M
Daiichi Sankyo 4568:JP Y 1345271M 34628M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Immunogen IMGN:US $ 456.72M 43.28M
Intrexon XON:US $ 154.94M 1.69M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Karyopharm Therapeutics KPTI:US $ 276.53M 927K
Ligand Pharmaceuticals LGND:US $ 276.07M 188.68M
Macrogenics MGNX:US $ 218.2M 61.36M
Neurocrine Biosciences NBIX:US $ 1018.2M 45.4M
Pfizer PFE:US $ 54420M 5273M
Regeneron Pharmaceuticals REGN:US $ 14306M 291.1M
Rigel Pharmaceuticals RIGL:US $ 138.94M 15.53M
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Ultragenyx Pharmaceutical RARE:US $ 707.52M 149.08M
Veracyte VCYT:US $ 238.48M 4.62M